Table 1.
STUDY PERIOD | |||||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
Enrollment | Allocation | Post-allocation | Close-out** | ||||||
| |||||||||
TIME POINT | -7d+ | -3d | 0d | 0d | 1d | 2d | 3d | 4d | 5d+ |
| |||||||||
ENROLLMENT: | |||||||||
|
|||||||||
High risk screen | X | ||||||||
|
|||||||||
Eligibility screen | X | ||||||||
|
|||||||||
Informed consent | X | ||||||||
|
|||||||||
Allocation | X | ||||||||
| |||||||||
INTERVENTIONS: | |||||||||
|
|||||||||
Propranolol | X | X | X | X | |||||
|
|||||||||
Psychological Education | X | X | X | ||||||
|
|||||||||
Placebo | X | X | X | X | |||||
|
|||||||||
General Education | X | X | X | ||||||
| |||||||||
ASSESSMENTS: | |||||||||
|
|||||||||
Demographic | X | ||||||||
|
|||||||||
Pain Intensity and Disability | X | X | X | X | X | X | |||
|
|||||||||
Physical Impairment | X | X | X | X | X | ||||
|
|||||||||
Psychological and Pain Sensitivity | X | X | X | X | X | ||||
|
|||||||||
Inflammatory Markers | X | X | X | X | |||||
|
|||||||||
Global Ratings and Blinding | X |
Time point units are days (d)
Participants continued to be followed after last post-allocation day if they do not meet pain recovery criterion for pain intensity and disability measures only.